Blue Jet Healthcare Limited (NSE:BLUEJET)
India
· Delayed Price · Currency is INR 749.55
-29.40 (-3.77%)
Feb 21, 2025, 3:30 PM IST
Blue Jet Healthcare Revenue
Blue Jet Healthcare had revenue of 3.18B INR in the quarter ending December 31, 2024, with 90.92% growth. This brings the company's revenue in the last twelve months to 8.73B, up 17.25% year-over-year. In the fiscal year ending March 31, 2024, Blue Jet Healthcare had annual revenue of 7.12B, down -1.30%.
Revenue (ttm)
8.73B
Revenue Growth
+17.25%
P/S Ratio
14.88
Revenue / Employee
19.54M
Employees
447
Market Cap
130.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 7.12B | -93.84M | -1.30% |
| Mar 31, 2023 | 7.21B | 375.13M | 5.49% |
| Mar 31, 2022 | 6.83B | 1.85B | 36.99% |
| Mar 31, 2021 | 4.99B | -392.63M | -7.30% |
| Mar 31, 2020 | 5.38B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |